Concepedia

Publication | Open Access

Circulating tumor DNA in unresectable pancreatic cancer is a strong predictor of first-line treatment efficacy: The KRASCIPANC prospective study

16

Citations

37

References

2023

Year

Abstract

ClinicalTrials.gov Identifier: NCT04560270.

References

YearCitations

Page 1